发布求助
文献互助 智能选刊 最新文献

B39. COPD MANAGEMENT: FROM PHARMACOLOGIC TREATMENT TO NOVEL THERAPIES最新文献

筛选
英文 中文
Mono-Bronchodilator Therapy versus Dual Bronchodilator Therapy in Symptomatic COPD Patients: The Korea COPD Subgroup Study Team Cohort 单支气管扩张剂治疗与双支气管扩张剂治疗对症COPD患者:韩国COPD亚组研究小组队列
B39. COPD MANAGEMENT: FROM PHARMACOLOGIC TREATMENT TO NOVEL THERAPIES Pub Date : 2022-05-01 DOI: 10.1164/ajrccm-conference.2022.205.1_meetingabstracts.a2790
Hong-Joon Shin, Tomoiku Kim, Y. Kwon
{"title":"Mono-Bronchodilator Therapy versus Dual Bronchodilator Therapy in Symptomatic COPD Patients: The Korea COPD Subgroup Study Team Cohort","authors":"Hong-Joon Shin, Tomoiku Kim, Y. Kwon","doi":"10.1164/ajrccm-conference.2022.205.1_meetingabstracts.a2790","DOIUrl":"https://doi.org/10.1164/ajrccm-conference.2022.205.1_meetingabstracts.a2790","url":null,"abstract":"","PeriodicalId":403586,"journal":{"name":"B39. COPD MANAGEMENT: FROM PHARMACOLOGIC TREATMENT TO NOVEL THERAPIES","volume":"92 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"126316993","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Prognostic Efficacy of Non-invasive Ventilation in Patients with Overlap Syndrome: Chronic Obstructive Pulmonary Disease and Obstructive Sleep Apnea 无创通气对重叠综合征患者的预后疗效:慢性阻塞性肺疾病和阻塞性睡眠呼吸暂停
B39. COPD MANAGEMENT: FROM PHARMACOLOGIC TREATMENT TO NOVEL THERAPIES Pub Date : 2022-05-01 DOI: 10.1164/ajrccm-conference.2022.205.1_meetingabstracts.a2799
J. Xie, Z. Fan
{"title":"Prognostic Efficacy of Non-invasive Ventilation in Patients with Overlap Syndrome: Chronic Obstructive Pulmonary Disease and Obstructive Sleep Apnea","authors":"J. Xie, Z. Fan","doi":"10.1164/ajrccm-conference.2022.205.1_meetingabstracts.a2799","DOIUrl":"https://doi.org/10.1164/ajrccm-conference.2022.205.1_meetingabstracts.a2799","url":null,"abstract":"","PeriodicalId":403586,"journal":{"name":"B39. COPD MANAGEMENT: FROM PHARMACOLOGIC TREATMENT TO NOVEL THERAPIES","volume":"141 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"128975453","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hospitalization Rates After Treatment of Pre-Identified COPD Exacerbations in Patients Utilizing Remote Patient Monitoring 利用远程患者监测治疗预先确定的COPD加重后的住院率
B39. COPD MANAGEMENT: FROM PHARMACOLOGIC TREATMENT TO NOVEL THERAPIES Pub Date : 2022-05-01 DOI: 10.1164/ajrccm-conference.2022.205.1_meetingabstracts.a2796
N. Moraveji, M. Polsky
{"title":"Hospitalization Rates After Treatment of Pre-Identified COPD Exacerbations in Patients Utilizing Remote Patient Monitoring","authors":"N. Moraveji, M. Polsky","doi":"10.1164/ajrccm-conference.2022.205.1_meetingabstracts.a2796","DOIUrl":"https://doi.org/10.1164/ajrccm-conference.2022.205.1_meetingabstracts.a2796","url":null,"abstract":"","PeriodicalId":403586,"journal":{"name":"B39. COPD MANAGEMENT: FROM PHARMACOLOGIC TREATMENT TO NOVEL THERAPIES","volume":"39 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"116195162","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pilot Study of O2asis: A Novel, Closed-System Heated Humidification Device for Individuals with COPD Requiring Supplemental Oxygen at Home O2asis的初步研究:一种新型、封闭系统的加热加湿设备，适用于需要在家补充氧气的慢性阻塞性肺病患者
B39. COPD MANAGEMENT: FROM PHARMACOLOGIC TREATMENT TO NOVEL THERAPIES Pub Date : 2022-05-01 DOI: 10.1164/ajrccm-conference.2022.205.1_meetingabstracts.a2797
R. Sandhaus, C. Strange, K.E. Holm
{"title":"Pilot Study of O2asis: A Novel, Closed-System Heated Humidification Device for Individuals with COPD Requiring Supplemental Oxygen at Home","authors":"R. Sandhaus, C. Strange, K.E. Holm","doi":"10.1164/ajrccm-conference.2022.205.1_meetingabstracts.a2797","DOIUrl":"https://doi.org/10.1164/ajrccm-conference.2022.205.1_meetingabstracts.a2797","url":null,"abstract":"","PeriodicalId":403586,"journal":{"name":"B39. COPD MANAGEMENT: FROM PHARMACOLOGIC TREATMENT TO NOVEL THERAPIES","volume":"43 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"117214075","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Investigational Microbiome Therapeutic SER-109 Reduces Recurrence of Clostridioides DifficileInfection (CDI) Compared to Placebo, Regardless of Presence or Absence of Comorbidities Including Chronic Obstructive Disease (COPD) and Asthma 与安慰剂相比，微生物组治疗性SER-109可减少艰难梭菌感染(CDI)的复发，无论是否存在包括慢性阻塞性疾病(COPD)和哮喘在内的合并症
B39. COPD MANAGEMENT: FROM PHARMACOLOGIC TREATMENT TO NOVEL THERAPIES Pub Date : 2022-05-01 DOI: 10.1164/ajrccm-conference.2022.205.1_meetingabstracts.a2792
B. Mcgovern, T. Louie, S. Cohen, M. Sims, E. Wang, H. Wu, K. Brady, L. V. von Moltke
{"title":"Investigational Microbiome Therapeutic SER-109 Reduces Recurrence of Clostridioides DifficileInfection (CDI) Compared to Placebo, Regardless of Presence or Absence of Comorbidities Including Chronic Obstructive Disease (COPD) and Asthma","authors":"B. Mcgovern, T. Louie, S. Cohen, M. Sims, E. Wang, H. Wu, K. Brady, L. V. von Moltke","doi":"10.1164/ajrccm-conference.2022.205.1_meetingabstracts.a2792","DOIUrl":"https://doi.org/10.1164/ajrccm-conference.2022.205.1_meetingabstracts.a2792","url":null,"abstract":"","PeriodicalId":403586,"journal":{"name":"B39. COPD MANAGEMENT: FROM PHARMACOLOGIC TREATMENT TO NOVEL THERAPIES","volume":"5 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"132239349","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Eligibility for COPD Clinical Trials of Inhaled Triple Therapy: Analysis of the Subpopulations and Intermediate Outcomes in COPD Study (SPIROMICS) 吸入三联治疗COPD临床试验的资格:COPD研究亚群和中期结果分析(SPIROMICS)
B39. COPD MANAGEMENT: FROM PHARMACOLOGIC TREATMENT TO NOVEL THERAPIES Pub Date : 2022-05-01 DOI: 10.1164/ajrccm-conference.2022.205.1_meetingabstracts.a2793
A. Lambert, L. Gravens-Mueller, L. Bateman, I. Barjaktarevic, R. Paine, N. Putcha, N. Hansel, J. Krishnan, M. Dransfield, S. Rogers, A. Shaikh, P. Woodruff, D. Couper, M. B. Drummond
{"title":"Eligibility for COPD Clinical Trials of Inhaled Triple Therapy: Analysis of the Subpopulations and Intermediate Outcomes in COPD Study (SPIROMICS)","authors":"A. Lambert, L. Gravens-Mueller, L. Bateman, I. Barjaktarevic, R. Paine, N. Putcha, N. Hansel, J. Krishnan, M. Dransfield, S. Rogers, A. Shaikh, P. Woodruff, D. Couper, M. B. Drummond","doi":"10.1164/ajrccm-conference.2022.205.1_meetingabstracts.a2793","DOIUrl":"https://doi.org/10.1164/ajrccm-conference.2022.205.1_meetingabstracts.a2793","url":null,"abstract":"","PeriodicalId":403586,"journal":{"name":"B39. COPD MANAGEMENT: FROM PHARMACOLOGIC TREATMENT TO NOVEL THERAPIES","volume":"253 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"134493668","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Impact of Oscillatory Positive Expiratory Pressure (OPEP) Therapy on Objectively Determined Cough and Sleep Disturbance in COPD: A Sub-Study from the O-COPD Trial 振荡呼气正压(OPEP)治疗对COPD患者客观确定的咳嗽和睡眠障碍的影响:O-COPD试验的一项亚研究
B39. COPD MANAGEMENT: FROM PHARMACOLOGIC TREATMENT TO NOVEL THERAPIES Pub Date : 2022-05-01 DOI: 10.1164/ajrccm-conference.2022.205.1_meetingabstracts.a2801
S. Alghamdi, A. AlAsmari, A.S. Alsulayyim, K. E. Philip, S. Birring, M. Polkey, N. Hopkinson
{"title":"Impact of Oscillatory Positive Expiratory Pressure (OPEP) Therapy on Objectively Determined Cough and Sleep Disturbance in COPD: A Sub-Study from the O-COPD Trial","authors":"S. Alghamdi, A. AlAsmari, A.S. Alsulayyim, K. E. Philip, S. Birring, M. Polkey, N. Hopkinson","doi":"10.1164/ajrccm-conference.2022.205.1_meetingabstracts.a2801","DOIUrl":"https://doi.org/10.1164/ajrccm-conference.2022.205.1_meetingabstracts.a2801","url":null,"abstract":"","PeriodicalId":403586,"journal":{"name":"B39. COPD MANAGEMENT: FROM PHARMACOLOGIC TREATMENT TO NOVEL THERAPIES","volume":"72 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"115548962","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparative Efficacy of UMEC/VI Versus Other Bronchodilators for the Treatment of COPD: A Systematic Literature Review and Network Meta-Analysis UMEC/VI与其他支气管扩张剂治疗COPD的疗效比较:系统文献综述和网络meta分析
B39. COPD MANAGEMENT: FROM PHARMACOLOGIC TREATMENT TO NOVEL THERAPIES Pub Date : 2022-05-01 DOI: 10.1164/ajrccm-conference.2022.205.1_meetingabstracts.a2791
A. Ismaila, A. Czira, K. Haeussler, V. Tongbram, M. Malmenäs, J. Agarwal, M. Nassim, M. Živković-Gojović, Y. Shen, M. Duarte, C. Compton
{"title":"Comparative Efficacy of UMEC/VI Versus Other Bronchodilators for the Treatment of COPD: A Systematic Literature Review and Network Meta-Analysis","authors":"A. Ismaila, A. Czira, K. Haeussler, V. Tongbram, M. Malmenäs, J. Agarwal, M. Nassim, M. Živković-Gojović, Y. Shen, M. Duarte, C. Compton","doi":"10.1164/ajrccm-conference.2022.205.1_meetingabstracts.a2791","DOIUrl":"https://doi.org/10.1164/ajrccm-conference.2022.205.1_meetingabstracts.a2791","url":null,"abstract":"","PeriodicalId":403586,"journal":{"name":"B39. COPD MANAGEMENT: FROM PHARMACOLOGIC TREATMENT TO NOVEL THERAPIES","volume":"22 4","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"121005872","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Meta-Analysis of Zephyr Endobronchial Valves for Management of Persistent Air Leaks Zephyr支气管内瓣膜治疗持续性漏气的meta分析
B39. COPD MANAGEMENT: FROM PHARMACOLOGIC TREATMENT TO NOVEL THERAPIES Pub Date : 2022-05-01 DOI: 10.1164/ajrccm-conference.2022.205.1_meetingabstracts.a2800
D. Hogarth, A. Wagh, A. Mahajan, B. Armstrong, N. Shargill, J. Travaline, G. Criner
{"title":"A Meta-Analysis of Zephyr Endobronchial Valves for Management of Persistent Air Leaks","authors":"D. Hogarth, A. Wagh, A. Mahajan, B. Armstrong, N. Shargill, J. Travaline, G. Criner","doi":"10.1164/ajrccm-conference.2022.205.1_meetingabstracts.a2800","DOIUrl":"https://doi.org/10.1164/ajrccm-conference.2022.205.1_meetingabstracts.a2800","url":null,"abstract":"","PeriodicalId":403586,"journal":{"name":"B39. COPD MANAGEMENT: FROM PHARMACOLOGIC TREATMENT TO NOVEL THERAPIES","volume":"89 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"124504007","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reducing Environmental Impact of Pressurised Metered Dose Inhalers: Relative Bioavailability of Budesonide/Glycopyrronium/Formoterol with Novel Propellant Formulations in Healthy Subjects 减少加压计量吸入器对环境的影响:新型推进剂布地奈德/甘替溴铵/福莫特罗在健康受试者中的相对生物利用度
B39. COPD MANAGEMENT: FROM PHARMACOLOGIC TREATMENT TO NOVEL THERAPIES Pub Date : 2022-05-01 DOI: 10.1164/ajrccm-conference.2022.205.1_meetingabstracts.a2798
M. Aurivillius, L. Dunsire, A. Bednarczyk, M. Kokot, J. Madriaga, J. Mei, K. Collison, R. Surujbally, M. Gillen
{"title":"Reducing Environmental Impact of Pressurised Metered Dose Inhalers: Relative Bioavailability of Budesonide/Glycopyrronium/Formoterol with Novel Propellant Formulations in Healthy Subjects","authors":"M. Aurivillius, L. Dunsire, A. Bednarczyk, M. Kokot, J. Madriaga, J. Mei, K. Collison, R. Surujbally, M. Gillen","doi":"10.1164/ajrccm-conference.2022.205.1_meetingabstracts.a2798","DOIUrl":"https://doi.org/10.1164/ajrccm-conference.2022.205.1_meetingabstracts.a2798","url":null,"abstract":"","PeriodicalId":403586,"journal":{"name":"B39. COPD MANAGEMENT: FROM PHARMACOLOGIC TREATMENT TO NOVEL THERAPIES","volume":"31 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"132711201","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
下一页 尾页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：481959085
Book学术官方微信